• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病不同阶段血液中犬尿氨酸、白细胞介素-23 和可溶性人白细胞抗原-G 的水平。

Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease.

机构信息

Faculty of Biomedical & Life Sciences, Neuroscience and Molecular Pharmacology, University of Glasgow, Glasgow, UK.

出版信息

J Neurochem. 2010 Jan;112(1):112-22. doi: 10.1111/j.1471-4159.2009.06442.x. Epub 2009 Oct 20.

DOI:10.1111/j.1471-4159.2009.06442.x
PMID:19845828
Abstract

There is substantial evidence that abnormal concentrations of oxidised tryptophan metabolites, produced via the kynurenine pathway, contribute to progressive neurodegeneration in Huntington's disease. We have now examined the blood levels of these metabolites in patients at different stages of Huntington's disease, assessed both in terms of clinical disease severity and numbers of CAG repeats. Close relatives of the patients were included in the study as well as unrelated healthy controls. Levels of lipid peroxidation products, the pro-inflammatory cytokine interleukin (IL)-23 and the soluble human leucocyte antigen-G (sHLA-G) were also measured. There were lower levels of tryptophan and a higher kynurenine : tryptophan ratio, indicating activation of indoleamine-2,3-dioxygenase, in the most severely affected group of patients, with increased levels of IL-23 and sHLA-G. Marked correlations were noted between IL-23 and the patient severity group, anthranilic acid levels and the number of CAG repeats, and between anthranilic acid and IL-23, supporting our previous evidence of a relationship between anthranilic acid and inflammatory status. Tryptophan was negatively correlated with symptom severity and number of CAG repeats, and positively correlated with sHLA-G. The results support the proposal that tryptophan metabolism along the kynurenine pathway in Huntington's disease is related to the degree of genetic abnormality, to clinical disease severity and to aspects of immunopathogenesis.

摘要

有大量证据表明,犬尿氨酸途径产生的氧化色氨酸代谢物浓度异常,导致亨廷顿病的进行性神经退行性变。我们现在已经检查了处于亨廷顿病不同阶段的患者的这些代谢物的血液水平,既根据临床疾病严重程度,也根据 CAG 重复次数进行了评估。该研究还包括了患者的近亲以及无关的健康对照者。还测量了脂质过氧化产物、促炎细胞因子白细胞介素 (IL)-23 和可溶性人类白细胞抗原-G (sHLA-G) 的水平。在病情最严重的患者组中,色氨酸水平较低,犬尿氨酸与色氨酸的比值较高,表明吲哚胺 2,3-双加氧酶被激活,IL-23 和 sHLA-G 水平升高。IL-23 与患者严重程度组、邻氨基苯甲酸水平和 CAG 重复次数之间,以及邻氨基苯甲酸与 IL-23 之间存在显著相关性,支持我们之前关于邻氨基苯甲酸与炎症状态之间存在关系的证据。色氨酸与症状严重程度和 CAG 重复次数呈负相关,与 sHLA-G 呈正相关。研究结果支持这样的假设,即亨廷顿病中犬尿氨酸途径的色氨酸代谢与遗传异常程度、临床疾病严重程度以及免疫发病机制的某些方面有关。

相似文献

1
Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease.亨廷顿病不同阶段血液中犬尿氨酸、白细胞介素-23 和可溶性人白细胞抗原-G 的水平。
J Neurochem. 2010 Jan;112(1):112-22. doi: 10.1111/j.1471-4159.2009.06442.x. Epub 2009 Oct 20.
2
Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.亨廷顿舞蹈症或慢性脑损伤患者的血液5-羟色胺、5-羟吲哚乙酸及褪黑素水平
J Neurochem. 2006 May;97(4):1078-88. doi: 10.1111/j.1471-4159.2006.03807.x. Epub 2006 Mar 29.
3
Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma.分析儿童特应性哮喘患者血浆可溶性人类白细胞抗原-G 和白细胞介素-10 水平。
Hum Immunol. 2010 Oct;71(10):982-7. doi: 10.1016/j.humimm.2010.06.018. Epub 2010 Jul 1.
4
Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.可溶性总人白细胞抗原 I 类分子和人白细胞抗原-G 分子在肾和肾/胰腺移植中的作用。
Hum Immunol. 2009 Dec;70(12):995-9. doi: 10.1016/j.humimm.2009.07.016. Epub 2009 Aug 6.
5
Soluble HLA-G molecule in patients with perennial allergic rhinitis.常年性变应性鼻炎患者体内的可溶性人类白细胞抗原G分子
Int Arch Allergy Immunol. 2009;150(3):278-81. doi: 10.1159/000222680. Epub 2009 Jun 4.
6
Decreased production of human leukocyte antigen G molecules in sinonasal polyposis.鼻息肉中人类白细胞抗原G分子的产生减少。
Am J Rhinol. 2008 Sep-Oct;22(5):468-73. doi: 10.2500/ajr.2008.22.3210.
7
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.系统性红斑狼疮中的HLA - G基因型与HLA - G表达:HLA - G作为系统性红斑狼疮的一个假定易感基因
Tissue Antigens. 2008 Jun;71(6):520-9. doi: 10.1111/j.1399-0039.2008.01037.x. Epub 2008 Mar 29.
8
Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.吲哚胺2,3-双加氧酶和人类白细胞抗原-G通过两条独立途径抑制T细胞同种异体增殖反应。
Immunology. 2005 Nov;116(3):297-307. doi: 10.1111/j.1365-2567.2005.02224.x.
9
Soluble HLA-G in rheumatoid arthritis.类风湿关节炎中的可溶性人类白细胞抗原G
Hum Immunol. 2006 Aug;67(8):561-7. doi: 10.1016/j.humimm.2006.03.023. Epub 2006 May 5.
10
[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].[三核苷酸重复扩增数目在亨廷顿舞蹈病临床表现中的重要性]
Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82.

引用本文的文献

1
Neuroinflammatory Proteins in Huntington's Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications.亨廷顿病中的神经炎症蛋白:对发病机制、诊断和治疗意义的深入了解。
Int J Mol Sci. 2024 Nov 2;25(21):11787. doi: 10.3390/ijms252111787.
2
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.神经活性色氨酸代谢产物作为药理学靶点:新的实验工具和令人兴奋的治疗机会。
Pharmacol Rev. 2024 Oct 16;76(6):978-1008. doi: 10.1124/pharmrev.124.000239.
3
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies.
中枢神经系统疾病中的色氨酸代谢:病理生理学及潜在治疗策略
Aging Dis. 2023 Jun 1;14(3):858-878. doi: 10.14336/AD.2022.0916.
4
Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy.神经退行性疾病中能量代谢和氨基酸代谢紊乱的代谢组学特征:早期诊断和治疗监测的前景
Metabolites. 2023 Mar 1;13(3):369. doi: 10.3390/metabo13030369.
5
The updated development of blood-based biomarkers for Huntington's disease.用于亨廷顿病的基于血液的生物标志物的最新进展。
J Neurol. 2023 May;270(5):2483-2503. doi: 10.1007/s00415-023-11572-x. Epub 2023 Jan 24.
6
An integrated cytokine and kynurenine network as the basis of neuroimmune communication.一个整合的细胞因子和犬尿氨酸网络作为神经免疫通讯的基础。
Front Neurosci. 2022 Nov 24;16:1002004. doi: 10.3389/fnins.2022.1002004. eCollection 2022.
7
Pathogenesis of Huntington's Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies.亨廷顿舞蹈症的发病机制:着重于分子途径及天然疗法的预防作用
Brain Sci. 2022 Oct 14;12(10):1389. doi: 10.3390/brainsci12101389.
8
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.阿尔茨海默病、帕金森病和亨廷顿病中美氨酸通路代谢物的动态变化:系统评价和荟萃分析。
Front Immunol. 2022 Oct 3;13:997240. doi: 10.3389/fimmu.2022.997240. eCollection 2022.
9
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders.色氨酸代谢:针对神经和精神疾病的基于机制的治疗方法。
Front Immunol. 2022 Sep 8;13:985378. doi: 10.3389/fimmu.2022.985378. eCollection 2022.
10
Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System.线粒体损伤:神经精神表现的常见特征?与色氨酸-犬尿氨酸代谢系统的关联。
Cells. 2022 Aug 21;11(16):2607. doi: 10.3390/cells11162607.